Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Immunotherapy has changed the treatment paradigm of numerous malignancies such as non-small cell lung cancer and melanoma. To date, there has been only modest demonstrable efficacy of immunotherapy for prostate cancer. This lack of efficacy is likely due to the immunosuppressive tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Dhruv, Reimers, Melissa A., Knoche, Eric M., Pachynski, Russell K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831137/
https://www.ncbi.nlm.nih.gov/pubmed/33477569
http://dx.doi.org/10.3390/cancers13020334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831137/
https://www.ncbi.nlm.nih.gov/pubmed/33477569
http://dx.doi.org/10.3390/cancers13020334

Ejemplares similares